Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Longeveron LLC

Longeveron LLC

LGVN · NASDAQ
LGVN · NASDAQ
6.93
USD6.23886.20%

Latest News

    @sspencer_smb
    sspencer_smb

    ystdy's #1 In Play $LGVN being bid up in the pre-market. https://t.co/PEbVkioSNR

      @yfinanceplus
      yfinanceplus

      Shares of $LGVN (Longeveron) are skyrocketing this morning on very heavy trading volume after the FDA gave its drug for treating a congenital heart defect in infants rare pediatric disease (RPD) designation. https://t.co/0lPKBmYTNo #stocks #trending https://t.co/Nh23WS6C2I

        @Benzinga
        Benzinga

        Top 10 PreMarket Movers from https://t.co/oazu0hpNce: $LGVN $TUSK $GTEC $UWMC $DPW $AQB $FLGC $BHTG $PROG $GRCL https://t.co/897Hr7CC2Q

          @maoxian
          maoxian

          Float rotation in $LGVN (using 2.68MM which can't be right) https://t.co/YdsFGyVdGq

            @Benzinga
            Benzinga

            $LGVN +190%👀 @LGVNSocial CEO and Co-Founder will be with us LIVE at 12:45pm ET! LINK: https://t.co/cRk26x2wIl https://t.co/8wyySXIQKG

            Analysts Recommendations

            Bullish

            Buy

            Strong Buy

            Buy

            Hold

            Sell

            Strong Sell

            Day Range

            6.60USD
            7.14USD

            52 Week Range

            0.47USD
            8.90USD

            Market Cap

            21.68MUSD

            lock-imagelock-image

            Get Full Access with Profit PRO

            See which Billionaires own this investment

            About

            General Information

            Type

            Common Stock

            Exchange

            NASDAQ

            Currency Code

            USD

            Currency Name

            US Dollar

            Country Name

            USA

            Country ISO

            US

            ISIN

            US54303L2034

            CUSIP

            54140W305

            Sector

            Healthcare

            Industry

            Biotechnology

            Fiscal Year End

            December

            IPO date

            -

            Updated At

            -

            Highlights

            PE Ratio

            -

            PEG Ratio

            -

            Book Value

            0.33

            Dividend Share

            -

            Dividend Yield

            -

            Earnings Share

            -10.24

            Wall Street Target Price

            71.50

            EPS Estimate Current Year

            -7.20

            EPS Estimate Next Year

            -4.70

            EPS Estimate Current Quarter

            -0.19

            EPS Estimate Next Quarter

            -0.15

            Most Recent Quarter

            -

            Profitability

            Revenue TTM

            1,187,000

            Gross Profit TTM

            828,000

            EBITDA

            -22,440,000

            Profit Margin

            0.00%

            Return On Assets TTM

            -90.95%

            Return On Equity TTM

            -203.61%

            Revenue Per Share TTM

            0.049

            Qtly Revenue Growth YOY

            -9.20%

            Diluted Eps TTM

            -10.24

            Qtly Earnings Growth YOY

            0.00%

            Valuation

            Trailing PE

            0.00

            Forward PE

            0

            Price Sales TTM

            1.889

            Price Book MRQ

            2.1056

            Enterprise Value Revenue

            10

            Enterprise Value EBITDA

            -49

            Peers analysis

            • Revolution Medicines Inc
              RVMDRevolution Medicines Inc

              221.93

              3.05%
            • argenx SE
              ARGNFargenx SE

              1020.00

              2.51%
            • argenx NV ADR
              ARGXargenx NV ADR

              1058.90

              1.20%
            • CSL Ltd
              CSLLYCSL Ltd

              31.33

              1.06%
            • UCB SA ADR
              UCBJYUCB SA ADR

              129.08

              0.46%
            • UCB SA
              UCBJFUCB SA

              267.59

              0.38%
            • CSL Limited
              CMXHFCSL Limited

              120.00

              0.00%
            • Moderna Inc
              MRNAModerna Inc

              141.01

              -5.79%
            • Regeneron Pharmaceuticals Inc
              REGNRegeneron Pharmaceuticals Inc

              807.39

              -0.94%
            • Vertex Pharmaceuticals Inc
              VRTXVertex Pharmaceuticals Inc

              545.01

              -0.42%
            XM

            Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

            Trade with a Trusted, Award-Winning Broker.

            Trading involves risk. The value of investments may go up or down. Trade responsibly.

            FAQs

            What is Longeveron LLC stock price today?

            What is Longeveron LLC stock ticker?

            Is LGVN stock price going up?

            What is the analyst recommendation for LGVN?

            What is LGVN market cap?

            Does LGVN release financial reports?

            When is LGVN next earnings date?

            What were LGVN Earnings for the last quarter?

            What was LGVN Revenue for the last quarter?

            What was LGVN Net Income for the last quarter?

            Does LGVN pay dividends?

            How many employees does LGVN have?

            What is LGVN EBITDA?

            How to buy LGVN stocks?

            Should I invest in LGVN stock?